Recall Radar
All recallsMedicine & devices

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured b…

Presence of Particulate matter: Particulate matter identified as glass.

Class I Medicine & devices FDA June 17, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. This recall is in the most serious category, meaning the agency believes it can cause serious injury or death — don't finish the package or use up what's left. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ
Severity
Class I — serious
Reported
June 17, 2026
Quantity
675 vials
Recall number
D-0580-2026
Status
Ongoing
Source
FDA

Where it went

U.S. Nationwide

Other medicine & devices recalls

See every current recall on the live dashboard →